cholestyramine resin has been researched along with cerivastatin in 3 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (cerivastatin) | Trials (cerivastatin) | Recent Studies (post-2010) (cerivastatin) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 556 | 91 | 46 |
| Protein | Taxonomy | cholestyramine resin (IC50) | cerivastatin (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.005 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.0001 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0001 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0056 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, R; Kuhlmann, J; Lücker, PW; Mück, W; Ritter, W; Wetzelsberger, N | 1 |
| Farnier, M | 1 |
| Kajinami, K; Koizumi, J; Mabuchi, H | 1 |
2 trial(s) available for cholestyramine resin and cerivastatin
| Article | Year |
|---|---|
Influence of cholestyramine on the pharmacokinetics of cerivastatin.
Topics: Absorption; Administration, Oral; Adolescent; Adult; Analysis of Variance; Anion Exchange Resins; Anticholesteremic Agents; Area Under Curve; Biological Availability; Blood Specimen Collection; Cholestyramine Resin; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Interactions; Enzyme Inhibitors; Fasting; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyridines | 1997 |
Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholesterol, HDL; Cholesterol, VLDL; Cholestyramine Resin; Female; Follow-Up Studies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Male; Middle Aged; Pyridines; Safety; Treatment Outcome; Triglycerides | 1998 |
1 other study(ies) available for cholestyramine resin and cerivastatin
| Article | Year |
|---|---|
Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Follow-Up Studies; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Pyridines; Safety; Treatment Outcome; Triglycerides | 1998 |